Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action
- PMID: 2500111
- DOI: 10.1001/archpsyc.1989.01810070051009
Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action
Abstract
It has been hypothesized that enhancement of brain serotoninergic (5-HT) function is involved in the mechanism of action of some antidepressants. To test this, the prolactin response to intravenously administered tryptophan, a clinical measurement of 5-HT function, was assessed before and during antidepressant treatment. Depressed patients received the tricyclic desipramine hydrochloride (N = 24) or the 5-HT reuptake inhibitor fluvoxamine maleate (N = 30). The prolactin response was significantly enhanced after long-term treatment (4 weeks) but not as reliably increased after short-term (1-week) desipramine treatment. Fluvoxamine enhanced the prolactin response after both short- and long-term treatment. Enhancement of the prolactin response was not clearly correlated with clinical improvement. The results of this study are consistent with preclinical evidence of enhanced 5-HT function during treatment with these classes of antidepressants, but also indicate that enhanced 5-HT function is not a sufficient condition for antidepressant efficacy.
Similar articles
-
The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.J Clin Psychiatry. 1990 Sep;51(9):367-72. J Clin Psychiatry. 1990. PMID: 2120201 Clinical Trial.
-
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.Arch Gen Psychiatry. 1990 Jun;47(6):577-85. doi: 10.1001/archpsyc.1990.01810180077011. Arch Gen Psychiatry. 1990. PMID: 2112374 Clinical Trial.
-
Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.Arch Gen Psychiatry. 1984 Apr;41(4):359-65. doi: 10.1001/archpsyc.1984.01790150049008. Arch Gen Psychiatry. 1984. PMID: 6703855 Clinical Trial.
-
Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.J Clin Psychiatry. 1990 Apr;51 Suppl:44-50; discussion 51-2. J Clin Psychiatry. 1990. PMID: 2182616 Review.
-
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):44S-49S. J Clin Psychopharmacol. 1987. PMID: 3123528 Review.
Cited by
-
Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.Drugs. 1993 Nov;46(5):895-924. doi: 10.2165/00003495-199346050-00008. Drugs. 1993. PMID: 7507038 Review.
-
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.Synapse. 2007 Jul;61(7):523-30. doi: 10.1002/syn.20398. Synapse. 2007. PMID: 17447260 Free PMC article. Clinical Trial.
-
Drugs and prolactin.Pituitary. 2008;11(2):209-18. doi: 10.1007/s11102-008-0106-6. Pituitary. 2008. PMID: 18404390 Review.
-
Antidepressant use and circulating prolactin levels.Cancer Causes Control. 2016 Jul;27(7):853-61. doi: 10.1007/s10552-016-0758-x. Epub 2016 May 10. Cancer Causes Control. 2016. PMID: 27165168 Free PMC article.
-
Serotonergic function during lithium augmentation of refractory depression.Psychopharmacology (Berl). 1992;108(1-2):93-7. doi: 10.1007/BF02245291. Psychopharmacology (Berl). 1992. PMID: 1410150
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical